These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21041083)

  • 1. Second generation analogs of rigid 6,7-spiro scaffolds targeting the bacterial ribosome.
    Stathakis CI; Mavridis I; Kythreoti G; Papakyriakou A; Katsoulis IA; Cottin T; Anastasopoulou P; Vourloumis D
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7488-92. PubMed ID: 21041083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rigid spiroethers targeting the decoding center of the bacterial ribosome.
    Mavridis I; Kythreoti G; Koltsida K; Vourloumis D
    Bioorg Med Chem; 2014 Feb; 22(4):1329-41. PubMed ID: 24457095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designed spiro-bicyclic analogues targeting the ribosomal decoding center.
    Cottin T; Pyrkotis C; Stathakis CI; Mavridis I; Katsoulis IA; Anastasopoulou P; Kythreoti G; Zografos AL; Nahmias VR; Papakyriakou A; Vourloumis D
    Chembiochem; 2011 Jan; 12(1):71-87. PubMed ID: 21154494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unnatural rigid scaffolds targeting the bacterial ribosome.
    Katsoulis IA; Pyrkotis C; Papakyriakou A; Kythreoti G; Zografos AL; Mavridis I; Nahmias VR; Anastasopoulou P; Vourloumis D
    Chembiochem; 2009 Aug; 10(12):1969-72. PubMed ID: 19585638
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
    Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides.
    Hu L; Lan P; Song QL; Huang ZJ; Sun PH; Zhuo C; Wang Y; Xiao S; Chen WM
    Eur J Med Chem; 2010 Dec; 45(12):5943-9. PubMed ID: 20970894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site.
    Barbault F; Ren B; Rebehmed J; Teixeira C; Luo Y; Smila-Castro O; Maurel F; Fan B; Zhang L; Zhang L
    Eur J Med Chem; 2008 Aug; 43(8):1648-56. PubMed ID: 18096272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into aminoglycoside action and resistance.
    Magnet S; Blanchard JS
    Chem Rev; 2005 Feb; 105(2):477-98. PubMed ID: 15700953
    [No Abstract]   [Full Text] [Related]  

  • 9. A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.
    Ranjith Kumar R; Perumal S; Senthilkumar P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Sep; 44(9):3821-9. PubMed ID: 19524332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns.
    Vaiana AC; Westhof E; Auffinger P
    Biochimie; 2006 Aug; 88(8):1061-73. PubMed ID: 16824662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regiospecific synthesis and biological evaluation of spirooxindolopyrrolizidines via [3+2] cycloaddition of azomethine ylide.
    Thangamani A
    Eur J Med Chem; 2010 Dec; 45(12):6120-6. PubMed ID: 20947223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA as a drug target: the case of aminoglycosides.
    Vicens Q; Westhof E
    Chembiochem; 2003 Oct; 4(10):1018-23. PubMed ID: 14523919
    [No Abstract]   [Full Text] [Related]  

  • 13. A Homo sapiens cytoplasmic ribosomal decoding A-site affinity screen evaluating aminoglycoside and analogue binding.
    Kythreoti G; Vourloumis D
    Anal Biochem; 2011 May; 412(1):102-7. PubMed ID: 21238425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.
    Borovinskaya MA; Pai RD; Zhang W; Schuwirth BS; Holton JM; Hirokawa G; Kaji H; Kaji A; Cate JH
    Nat Struct Mol Biol; 2007 Aug; 14(8):727-32. PubMed ID: 17660832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of privileged scaffolds by using diversity-oriented synthesis.
    Surakanti R; Sanivarapu S; Thulluri C; Iyer PS; Tangirala RS; Gundla R; Addepally U; Murthy YL; Velide L; Sen S
    Chem Asian J; 2013 Jun; 8(6):1168-76. PubMed ID: 23512685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.
    Katsoulis IA; Kythreoti G; Papakyriakou A; Koltsida K; Anastasopoulou P; Stathakis CI; Mavridis I; Cottin T; Saridakis E; Vourloumis D
    Chembiochem; 2011 May; 12(8):1188-92. PubMed ID: 21557427
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies.
    Yang G; Trylska J; Tor Y; McCammon JA
    J Med Chem; 2006 Sep; 49(18):5478-90. PubMed ID: 16942021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens.
    Liou GF; Yoshizawa S; Courvalin P; Galimand M
    J Mol Biol; 2006 Jun; 359(2):358-64. PubMed ID: 16626740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.
    Foloppe N; Chen IJ; Davis B; Hold A; Morley D; Howes R
    Bioorg Med Chem; 2004 Mar; 12(5):935-47. PubMed ID: 14980606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis and biological evaluation of spirotryprostatin A analogs.
    Ma Y; Fan C; Jia B; Cheng P; Liu J; Ma Y; Qiao K
    Chirality; 2017 Nov; 29(11):737-746. PubMed ID: 28906026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.